SCHEMBL7011332

SCHEMBL7011332

Nc1cc(-n2cc(C(=O)O)c(=O)c3c(N)c(F)c(N4CC[C@H](N)C4)c(F)c32)c(F)cc1F

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 14/20 0.53
TOP2B Q02880 10/20 0.53
TOP1 P11387 3/20 0.53
POLB P06746 2/20 0.48
CACNA1F O60840 1/20 0.48
MAPK1 P28482 1/20 0.48
CACNA1D Q01668 1/20 0.48
KCNH2 Q12809 1/20 0.48
CACNA1S Q13698 1/20 0.48
CACNA1C Q13936 1/20 0.48
ALDH1A1 P00352 1/20 0.47
CHRM2 P08172 1/20 0.47
CHRM1 P11229 1/20 0.47
OPRM1 P35372 1/20 0.47
OPRD1 P41143 1/20 0.47
SLC2A1 P11166 1/20 0.46
KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8478277 1.00 TOP2A (0.53) TOP2ATOP2BTOP1POLBCACNA1F
SCHEMBL7010194 0.93 CACNA1F (0.51) TOP2ATOP2BTOP1POLBCACNA1F
SCHEMBL5868717 0.89 KMT2A (0.60) TOP2ATOP2BTOP1POLBCACNA1F
SCHEMBL7013670 0.86 TOP2A (0.64) TOP2ATOP2BTOP1POLBALDH1A1
SCHEMBL7005373 0.85 CYP3A4 (0.53) TOP2ATOP2BTOP1POLBCACNA1F
SCHEMBL7014564 0.84 CYP3A4 (0.46) TOP2ATOP2BTOP1POLBCACNA1F
SCHEMBL7004713 0.84 TOP2A (0.57) TOP2ATOP2BTOP1POLBALDH1A1
SCHEMBL8482489 0.84 TOP2A (0.57) TOP2ATOP2BTOP1POLBALDH1A1
SCHEMBL7004969 0.81 ALDH1A1 (0.69) TOP2ATOP2BTOP1POLBALDH1A1
SCHEMBL8479016 0.81 ALDH1A1 (0.69) TOP2ATOP2BTOP1POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0787720-B1 PYRIDONECARBOXYLATE DERIVATIVE OR SALT THEREOF AND ANTIBACTERIAL CONTAINING THE SAME AS ACTIVE INGREDIENT WAKUNAGA SEIYAKU KK (JP) 2003-07-16 EP disclosed
US-5910498-A NOVEL COMPOUNDS HAVING REDUCED CYTOTOXICITY, PHOTOTOXICITY; TREATING BACTERIAL AND VIRAL INFECTIONS WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) 1999-06-08 US disclosed
EP-0787720-A1 NOVEL PYRIDONECARBOXYLATE DERIVATIVE OR SALT THEREOF AND ANTIBACTERIAL CONTAINING THE SAME AS ACTIVE INGREDIENT WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) 1997-08-06 EP disclosed